Hereditary Cancer Panel

Name: Hereditary Cancer Panel
Price: 6800 HKD
Availability: InStock

Hereditary cancers account for approximately 5–10% of all cancers. People who carry inherited genetic variants may be more likely to develop certain cancers at a younger age than the general population. Understanding your genetic information may help individuals at higher risk discuss appropriate health surveillance and risk management with healthcare professionals.

The BGI SENTIS Hereditary Cancer Panel analyses 108 genes associated with 26 major hereditary cancers, providing useful information to support personal and family health management.

Test Features

108 Genes

Comprehensive analysis of hereditary cancer-related genetic information.

26 Hereditary Cancers

Covers a wide range of common, hereditary and familial cancers.

Simple Sample Collection

5mL peripheral blood / 2mL saliva*

* Final sample collection arrangements are subject to Seed Medical's actual service arrangements.

Covers 26 Types of Hereditary Cancer

Common Cancers

Breast Cancer, Ovarian Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer, Gastric Cancer, Pancreatic Cancer, Thyroid Cancer, Endometrial Cancer, Esophageal Cancer, Biliary Tract Cancer, Renal Cell Carcinoma, Urothelial Carcinoma / Bladder Cancer, Melanoma

Hereditary / Familial Tumours

Familial Paraganglioma / Pheochromocytoma, Familial Neuroblastoma, Familial Wilms Tumor, Parathyroid Cancer, Adrenal Cortical Tumor

Other Hereditary Tumours / Tumour Syndromes

Multiple Endocrine Neoplasia Type I / II / IV, Neurofibromatosis, Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome), Chondrosarcoma, Gastrointestinal Stromal Tumor, Tuberous Sclerosis, Retinoblastoma
Cancer Patients

Genetic information from the test may help to:

Understand possible hereditary causes
Provide further insight into whether a cancer may be associated with an inherited genetic factor.

Support treatment and clinical management decisions
Certain genetic findings may help inform treatment decisions and clinical management, including information relevant to PARP inhibitors as referenced in BGI materials.

Assess the risk of other cancers
Help identify whether other hereditary cancer risks may require further attention.

Provide risk information for blood relatives
Genetic findings may also support risk assessment and health management for family members.

Healthy Individuals and Blood Relatives

The test may help to:

Assess genetic risks associated with hereditary cancers

Discuss appropriate follow-up health management with healthcare professionals if a relevant pathogenic variant is identified

Support risk assessment for blood relatives when a known familial genetic variant has already been identified
Hereditary cancer genetic testing primarily provides information about inherited cancer risk. It is not intended to diagnose whether you currently have cancer.

A genetic test result does not mean that you will definitely develop, or never develop, cancer in the future. Cancer risk may also be influenced by age, lifestyle and other factors.

Genetic test results may have implications for biological family members. These potential implications should be considered before testing.

If you have symptoms suggestive of cancer, abnormal test results or concerns about possible cancer, you should seek medical assessment rather than relying solely on hereditary cancer genetic testing.

This test does not replace routine cancer screening or other clinical examinations recommended by your doctor.
1. Does a positive result mean that I already have cancer?

Not necessarily. This test is designed to assess genetic risk associated with hereditary cancers. If a relevant pathogenic variant is identified, it may indicate an increased risk of certain cancers. Appropriate surveillance and risk management can then be discussed with healthcare professionals.

2. If a hereditary genetic variant is identified, should my family members also be tested?

It depends on the test result and your family history. If a hereditary cancer-related variant is identified, BGI materials suggest that blood relatives may consider testing for the relevant variant to help clarify their individual risk.

3. Is genetic testing still useful if I have already been diagnosed with cancer?

Yes. For cancer patients, hereditary genetic information may help clarify a possible hereditary cause, support certain treatment and clinical management decisions, and assess the risk of other cancers. BGI materials also note that some genetic findings may provide information relevant to treatment options such as PARP inhibitors.

4. What happens after the test?

BGI's full testing workflow includes result interpretation, report issuance, counselling and healthcare management. Actual follow-up arrangements may vary depending on the test result and individual circumstances.

5. Can hereditary cancer genetic testing replace regular cancer screening?

No. Genetic testing is intended to support risk assessment and health management rather than replace routine cancer screening. In BGI's case example, an individual with a BRCA1 pathogenic variant was still advised to undergo regular breast, pelvic and other relevant examinations.